# EDGAR Filing Document

**Accession Number:** 0001792044
**File Stem:** 0001140361-26-021672
**Filing Date:** 2026-5
**Character Count:** 6762
**Document Hash:** 293381957e887e87bfaea9c36944b1e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-021672.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001140361-26-021672

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260515

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Viatris Inc
- **CENTRAL INDEX KEY:** 0001792044
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 834364296
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39695
- **FILM NUMBER:** 26988471

**BUSINESS ADDRESS:**
- **STREET 1:** 1000 MYLAN BOULEVARD
- **CITY:** CANONSBURG
- **STATE:** PA
- **ZIP:** 15317
- **BUSINESS PHONE:** (724) 514-1465

**MAIL ADDRESS:**
- **STREET 1:** 1000 MYLAN BOULEVARD
- **CITY:** CANONSBURG
- **STATE:** PA
- **ZIP:** 15317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Upjohn Inc
- **DATE OF NAME CHANGE:** 20191023

?xml version='1.0' encoding='ASCII'?

------

**UNITED STATES**

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): May 15, 2026

------

## VIATRIS INC.

#### (Exact name of registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
| **Delaware**<br>| **001-39695**  | **83-4364296**<br>|
| **(State or Other Jurisdiction of Incorporation)**  | **(Commission File Number)** | **(I.R.S. Employer Identification No.)** |

---

#### 1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317

#### (Address of Principal Executive Offices)

#### Registrant's telephone number, including area code: (724) 514-1800

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
|  | **Trading** | **Name of each exchange** |
| **Title of each class** | **Symbol(s)** | **on which registered** |
| Common Stock, par value $0.01 per share<br>| VTRS<br>| The NASDAQ Stock Market<br>|

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.** |

---

(a) On May 15, 2026, Viatris Inc. ("Viatris" or the "Company") held its 2026 annual meeting of shareholders (the "2026 Annual Meeting"). At the 2026 Annual Meeting, shareholders were asked to consider and act upon the following items of business: (i) elect thirteen director nominees, each to hold office until the 2027 annual meeting of shareholders; (ii) approve, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company; and (iii) ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. With respect to each proposal below, abstentions and broker non-votes were considered for purposes of establishing a quorum but were not considered to be votes cast and therefore had no effect on the vote on any such proposal.

(b) The certified results of the matters voted on at the 2026 Annual Meeting are set forth below.

Proposal No. 1 - Election of the following thirteen director nominees, each to hold office until the 2027 annual meeting of shareholders:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Nominee</u>** | **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| W. Don Cornwell | 849532867 | 24182514 | 1841533 | 122461640 |
| Frank D'Amelio | 867382258 | 7361498 | 813158 | 122461640 |
| JoEllen Lyons Dillon | 798545833 | 59938622 | 17072459 | 122461640 |
| Elisha Finney | 871844773 | 2902953 | 809188 | 122461640 |
| Leo Groothuis | 854806833 | 19923045 | 827036 | 122461640 |
| Melina Higgins | 870698982 | 4042667 | 815265 | 122461640 |
| James M. Kilts | 856659003 | 18077659 | 820252 | 122461640 |
| Richard Mark | 869902473 | 4817061 | 837380 | 122461640 |
| Mark Parrish | 810773873 | 63952809 | 830232 | 122461640 |
| Michael Severino | 871428340 | 3309576 | 818998 | 122461640 |
| David Simmons | 857208158 | 17530423 | 818333 | 122461640 |
| Scott A. Smith | 871094570 | 3622333 | 840011 | 122461640 |
| Rogério Vivaldi Coelho | 871117588 | 3593152 | 846174 | 122461640 |

---

Each director nominee was elected to hold office until the 2027 annual meeting of shareholders.

Proposal No. 2 – Approval, on a non-binding advisory basis, of the 2025 compensation of the named executive officers of the Company:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 846,370,157 | 26,920,688 | 2,266,069 | 122,461,640 |

---

This proposal was approved.

Proposal No. 3 – Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 969,259,214 | 27,657,863 | 1,101,477 | N/A |

---

This proposal was approved.

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | VIATRIS INC. | VIATRIS INC. |
| Date: May 15, 2026 | By: | /s/ Matthew Maletta |
|  |  | Matthew Maletta |
|  |  | Chief Legal Officer |

---

------